In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence

NACompletedINTERVENTIONAL
Enrollment

517

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

October 13, 2022

Conditions
Smoking Reduction or Abstinence
Interventions
BEHAVIORAL

In vivo counseling

Participants in the intervention group will receive 4 in session nicotine replacement therapy and counseling focused on their experience of using NRT, including positive experiences, side effects and smoking cessation expectancies. They will also received nicotine replacement therapy (nicotine lozenge and patch) to use for smoking cessation.

BEHAVIORAL

Standard Smoking Cessation Counseling

Participants will receive 4 sessions of standard behavioral counseling to address their smoking. In addition, participants will received nicotine replacement therapy (Nicotine lozenge and patch) to use for smoking cessation.

Trial Locations (1)

Unknown

UAB Substance Abuse, Birmingham

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT02938403 - In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence | Biotech Hunter | Biotech Hunter